VALD, based in Australia, is revolutionizing the field of musculoskeletal technology, earning its status as a world leader. Since its inception in 2015, the company has shifted the paradigm in musculoskeletal assessment and rehabilitation, catering to elite sports organizations, clinics, universities, hospitals, and defense departments globally.
The comprehensive VALD Suite offers cutting-edge technology, including the ForceDecks Dual Force Plate System, NordBord Hamstring Testing System, and AirBands Blood Flow Restriction Cuffs, among others. These tools are pivotal for measuring human movement, enhancing performance, and facilitating injury rehabilitation.
The recent $36.00M venture round on 28 November 2022, led by prominent investors Vistara Growth and Queensland Investment Corporation, underscores VALD's strong market position in the Health and Wellness and Sports industries. As the company continues to innovate and expand, it presents a compelling opportunity for investors seeking exposure to cutting-edge healthcare and performance technology.